Microbiologist ➡️ ID Pharmacist 🧫🦠💊 | PGY1 & PGY2 ID @UHPharmRes | 🎓@UTexasPharmacy🤘🏽| Proud Latina Immigrant | Patient Advocate for all
San Antonio, TX
Joined November 2019
- Tweets1.2K
- Following202
- Followers275
- Likes3K
Samantha Aguilar, PharmD, BCIDP, AAHIVP retweeted
The @US_FDA approval of a new mRNA flu vaccine is welcome news, providing another important option to help protect people from a virus that sends hundreds of thousands of Americans to the hospital each year & claims thousands of lives.
Our statement: bit.ly/4w94CpG
Samantha Aguilar, PharmD, BCIDP, AAHIVP retweeted
A great reference for the management of beta lactam allergy – at Udupi, India
🔥Just published 🔥
ESCMID Clinical Guidelines on the Evaluation and Management of a Reported Antibiotic Allergy #IDXposts
clinicalmicrobiologyandinfec…
ALT Beta lactams flow shart
Samantha Aguilar, PharmD, BCIDP, AAHIVP retweeted
🔥🔥IDSA AMR Guidance 2026🔥🔥
🔺Notable Updates from the 2024 IDSA AMR Guidance Document
IDSA 2026 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections
🔺ESBL, AmpC Enterobacterales
🔺CRE
🔺DTR P. aeruginosa
🔺CRAB
🔺Stenotrophomonas maltophilia
Including updates in antimicrobial selection, dosing strategies, and management approaches.
🔺Meropenem dosing update: individualized dosing approach (1–2 g IV q8h) with higher doses considered in selected clinical scenarios.
Info inspired / credit to @RabeaAgeeli , #IDXposts
idsociety.org/practice-guide…
🤖 Made with AI
Samantha Aguilar, PharmD, BCIDP, AAHIVP retweeted
The problem: Syphilis testing is terrible.
The challenge: Explain it anyway.
The result: This piece.
(Free link in replies) @NEJM @NEJMClinician
Samantha Aguilar, PharmD, BCIDP, AAHIVP retweeted
The RODEO trials are the biggest multicentre randomised controlled trials to assess non-inferiority of oral switch of antibiotic therapy as compared with entirely intravenous antibiotic therapy in adult patients with left-sided IE due to Gram-positive cocci (staphylococci for RODEO 1, streptococci and enterococci for RODEO 2). #idxposts
Samantha Aguilar, PharmD, BCIDP, AAHIVP retweeted
🆕💥🟢DigiSep trial
In patients with sepsis or septic shock the detection of microbial circulating cell-free DNA by metagenomic next-generation sequencing (mNGS) in addition to routine microbiological diagnostics FAILED to improve the DOOR/RADAR score* as primary endpoint in the intervention group. #idxposts
link.springer.com/article/10…
Samantha Aguilar, PharmD, BCIDP, AAHIVP retweeted
🆕💥🟢Review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBa #IDXposts academic.oup.com/jac/article…
Samantha Aguilar, PharmD, BCIDP, AAHIVP retweeted
🆕💥🔴 ASTARTÉ RCT
In patients with bacteraemia caused by third-generation cephalosporin-resistant Enterobacterales, temocillin was non-inferior to carbapenems as targeted treatment #idxposts
3GCR-E # ESBL
thelancet.com/journals/lance…
Samantha Aguilar, PharmD, BCIDP, AAHIVP retweeted
🔥 Great commentary 🔥 @BradSpellberg
Procalcitonin—An Enigmatic Anxiolytic Biomarker
The anxiolytic power of a low PCT, bolstered by the largest RCT database of any diagnostic test, helps scared clinicians avoid unnecessary and potentially harmful therapy for such patients. #idxposts
jamanetwork.com/journals/jam…
Samantha Aguilar, PharmD, BCIDP, AAHIVP retweeted
🦠C. difficile感染エキスパートレビュー
- ⚡️AGAより
- 病院内では適切な消毒を実施、家庭内感染は稀であることを患者に伝える
- 検査陰性でも感染が強く疑われれば治療を開始する
- 重症度を評価して、治療方針を決定する
- 治療効果確認のための検査は実施しない
- 併存疾患や継続的な抗菌薬使用が必要な場合は低用量VCM125mg/日の継続投与を考慮
- 劇症型では多職種チームによる集学的管理でVCM+MNZで治療する
- VCMの予防投与は推奨されない
- 不要なPPIは中止する、不必要な抗菌薬は避けるよう患者に指導する
【ガイドライン】成人におけるClostridioides difficile感染症管理に関するAGAの診療アップデート: 専門家のレビュー（全文フリー） #ペ読
pubmed.ncbi.nlm.nih.gov/4238…
Samantha Aguilar, PharmD, BCIDP, AAHIVP retweeted
🧵 FIEBRE DE ORIGEN DESCONOCIDO (FOD) 2026 🔥
🚨 NUEVA DEFINICIÓN DE FOD (Delphi 2024–IDSA 2026)
✅ Fiebre ≥38,3°C en >3 ocasiones
✅ >3 semanas
✅ Sin dx tras estudio mínimo estandarizado
✅ inmunocompetente
La FOD ya no es sólo una definición temporal.
Samantha Aguilar, PharmD, BCIDP, AAHIVP retweeted
🚨IV fosfo finally FDA approved in US for cUTI d/t E. coli or Kleb pneumo.
-Cost?
-Folks willing to use it for Kleb (or other Enterobacterales) in the absence of CLSI BPs?
-Dose: 6G IV q8h…Tolerability in real-world? 🤔
Lots of questions to consider….
#IDTwitter #TwitteRx
🔥Meitheal Pharmaceuticals Receives Approval from the US FDA for CONTEPO™ (fosfomycin) for injection in Patients ≥ 18 Years Having Complicated Urinary Tract Infections (cUTI),Including Acute Pyelonephritis🔥
Thanks @highlycritical1 share.google/W1ibdyQJ6Gt6qRo…
Apply to our PGY1 Pharmacy Residency Program at Ochsner LSU Health Shreveport!
💊 Learn more about our program: lnkd.in/eftPgv36 💊
#PharmacyResidency #PGY1 #OchsnerLSUHealth #PhORCAS #ClinicalPharmacy #ASHP #PharmacyLeadership #ResidencyRecruitment
Samantha Aguilar, PharmD, BCIDP, AAHIVP retweeted
🔥2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Group A Streptococcal (GAS) Pharyngitis: Risk assessment
using clinical scoring systems in children and adults🔥 #IDXposts
idsociety.org/practice-guide…
Samantha Aguilar, PharmD, BCIDP, AAHIVP retweeted
Update Guidelines on Occupational HIV PEP
🔑Recommendations:
-Start PEP ASAP and within 72hrs
-Preferred: BIC/FTC/TAF or DTG/XTC/TXF, for 28 days
-Final test at week 12
-Shared decision making (forgo PEP or stop early) if source has undetectable HIV RNA
doi.org/10.1017/ice.2025.102…
Samantha Aguilar, PharmD, BCIDP, AAHIVP retweeted
New and emerging drugs for the treatment of invasive fungal infections
doi.org/10.1080/14656566.202…
Samantha Aguilar, PharmD, BCIDP, AAHIVP retweeted
Do you still see and manage COVID-19 patients ?!
🆕🔥 IDSA Guidelines on the Treatment and Management of Patients with COVID-19
COVID-19 severity
Approach in mild mod
Bari Vs Toci
#IDXposts
idsociety.org/practice-guide…
Samantha Aguilar, PharmD, BCIDP, AAHIVP retweeted
🔥Just published
The GAME CHANGER RCT
Among patients with a hospital-acquired or health-care-associated Gram-negative bloodstream infection, cefiderocol resulted in non-inferior but not superior 14-day mortality compared with standard of care #IDXposts share.google/wnXjZuhBYFBOA3Z…
Samantha Aguilar, PharmD, BCIDP, AAHIVP retweeted
In the S. aureus methicillin-susceptible experimental #endocarditis model, daptomycin combinations with β-lactams had better activity than monotherapies in sterilizing valve vegetations. These findings support their use in clinical practice @hospitalclinic academic.oup.com/jid/article…
Samantha Aguilar, PharmD, BCIDP, AAHIVP retweeted
How I manage patients with New Delhi
metallo-beta-lactamase and OXA-48 producing Enterobacterales infections: a practical approach
journals.lww.com/co-infectio…
